News
Strides Pharma Science consolidated net profit rises 2.60% in the September 2026 quarter
30-Oct-2026 | 07:38
Sales rise 17.11% to Rs 1429.73 crore
Net profit of Strides Pharma Science rose 2.60% to Rs 130.84 crore in the quarter ended September 2026 as against Rs 127.53 crore during the previous quarter ended September 2025. Sales rose 17.11% to Rs 1429.73 crore in the quarter ended September 2026 as against Rs 1220.83 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 1429.73 | 1220.83 | 17 |
| OPM % | 17.55 | 18.88 | - |
| PBDT | 209.35 | 211.53 | -1 |
| PBT | 152.14 | 161.89 | -6 |
| NP | 130.84 | 127.53 | 3 |
Powered by Capital Market - Live News